| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.002 |